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Abstract
Human immunodeficiency virus type 1 (HIV-1) infection is in general established by CCR5-utilizing (R5) virus variants, which persist
throughout the course of infection. R5 HIV-1 variants evolve into CXCR4-utilizing (X4) HIV-1 variants in approximately half of the
infected individuals. We have previously observed an ongoing genetic evolution with a continuous divergence of envelope gp120 sequences
of coexisting R5 and X4 virus variants over time. Here, we studied evolution of gag p17 sequences in two patients who developed X4
variants in the course of infection. In contrast to the envelope gp120 sequences, gag p17 sequences of R5 and X4 virus populations
intermingled in phylogenetic trees and did not diverge from each other over time. Statistical evaluation using the Shimodaira–Hasegawa test
indicated that the different genomic regions evolved along different topologies, supporting the hypothesis of recombination. Therefore, our
data imply that recombination between R5 and X4 HIV-1 variants occurs in vivo.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) corecep-
tor preference is a major determinant of cellular tropism.
Chemokine receptors CCR5 and CXCR4 are the main co-
receptors for entry of HIV-1 into CD4 cells (Doms and
Peiper, 1997; Hoffman and Doms, 1998; Berger et al., 1998,
1999; De Roda Husman and Schuitemaker, 1998). CCR5-
utilizing (R5), non-syncytium-inducing (NSI) variants pre-
dominate in the early phase of HIV-1 infection. In approx-
imately half of the HIV-1-infected individuals, CXCR4-
utilizing (X4), syncytium-inducing (SI) HIV-1 variants
emerge in the course of infection (Koot et al., 1993; Connor
et al., 1997; Scarlatti et al., 1997; van Rij et al., 2000). At
the moment it is still unclear why X4 variants become
detectable in only half of the infected individuals.
CCR5 is mainly expressed on activated memory cells
(Bleul et al., 1997). Consequently, predominantly memory
CD4 T cells are infected in patients in whom X4 variants
have not evolved. X4 HIV-1 variants can infect both naive
and resting memory CD4 T cells, which express CXCR4
(Blaak et al., 2000; van Rij et al., 2000; Bleul et al., 1997;
Eckstein et al., 2001). In the SCID-hu-thy/liv model, X4
variants display faster replication kinetics and cause a more
rapid and more severe depletion of thymocytes than R5
HIV-1 variants (Berkowitz et al., 1998; Camerini et al.,
2000). The development of X4 variants thus provides the
virus population with an expanding target cell population,
which includes naive CD4 T cells and thymocytes. Infection
of naive T cells (and thymocytes) by X4 variants interferes
with T cell renewal and may therefore cause the more rapid
CD4 T cell decline that is observed after the development of
X4 HIV-1 variants (Blaak et al., 2000; Koot et al., 1993;
Feinberg et al., 2002).
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After the emergence of X4 variants in vivo, R5 and X4
HIV-1 variants continuously coexist and both virus popu-
lations may even expand (Van’t Wout et al., 1998; Koot et
al., 1996; van Rij et al., 2000). We hypothesized that the
differential expression of CCR5 and CXCR4 on naive and
memory cells provides R5 and X4 variants with distinct
nonoverlapping target cell populations. These distinct target
cells could function as cellular niches, allowing the coex-
istence of both variants within an infected individual (van
Rij et al., 2000).
We previously studied the evolution of gp120 V3 span-
ning region in patients who developed X4 HIV-1 variants in
the course of infection (van Rij et al., 2000; Van’t Wout et
al., 1998). We observed an ongoing evolution of the V3
region of gp120 of both R5 and X4 variants after the
emergence of X4 variants. Early X4 variants clustered
closer to the R5 virus population than later X4 variants. All
X4 HIV-1 sequences were observed on a single branch in
the phylogenetic tree, implying that successful establish-
ment of X4 variants occurs only once in the course of
infection. Envelope sequences of the R5 and X4 virus pop-
ulations continuously diverged, suggesting that both virus
populations do not interact after the evolution of X4 HIV-1
variants.
To further substantiate these findings, we analyzed ge-
netic evolution of the gag p17 sequences of R5 and X4
HIV-1 variants from two patients in the course of infection.
We chose to study evolution of gag p17 as it has been
shown that this is a relatively variable genomic region that
is suitable to study virus evolution within and between
patients (Kasper et al., 1995; Hughes et al., 1997; Albert et
al., 1994; Holmes et al., 1995; Louwagie et al., 1993).
Furthermore, the gag gene is not directly involved in viral
entry, whereas the gp120 V3 region is the major determi-
nant for coreceptor preference. Finally, in the gag p17
region predominantly synonymous mutations are observed,
which are not subject to positive selection pressures (Seibert
et al., 1995; Hughes et al., 1997; Kasper et al., 1995; Brown
and Monaghan, 1988).
Results
From two patients (ACH039 and ACH208) who devel-
oped X4 HIV-1 variants, we sequenced the gag p17 region
and a small part of the gag p24 region of coexisting R5 and
X4 HIV-1 clones that were obtained at several time points
after the moment of SI/X4 conversion. The deduced amino
acid sequence is shown in Fig. 1. In both patients amino
acid substitutions accumulated over time. Several of these
amino acid substitutions are conservative (e.g., I72V, E83D
in ACH039; E92D, 194V in ACH208, etc.), suggesting
relatively strict restrictions to the nature of substitutions that
are allowed in this region.
The overall diversity in the gag p17 region was 0.015 
0.007 and 0.019  0.010 for ACH039 and ACH208, re-
spectively (average of all pairwise distances  standard
deviation). This was lower than the diversity in the gp120
V3 region (0.036 0.016 and 0.050 0.026, respectively).
We analyzed the overall estimate of the rate of synonymous
and nonsynonymous mutations per potential site for gp120
V3 and gag p17 sequences from ACH039 and ACH208
(Table 1). In p17 the rate of synonymous mutations was
higher than the rate of nonsynonymous mutations for both
patients, whereas the opposite is true for the gp120 V3
sequences, confirming previous studies (Seibert et al., 1995;
Hughes et al., 1997; Kasper et al., 1995; Brown and Mon-
aghan, 1988). Thus, the larger overall diversity in the gp120
V3 region is mainly due to a higher rate of nonsynonymous
mutations. The gag region is therefore expected to be less
subject to positive selection than the gp120 V3 region.
An unrooted neighbor-joining tree was produced of all
gag p17 sequences of ACH039 and ACH208 (Fig. 2). As
expected, sequences of each patient displayed a separate
bootstrap- supported clustering. A temporal structure can be
observed in both patients. Sequences obtained late in infec-
tion clustered on a separate branch than early sequences.
This clustering is supported by bootstrap values over 70 in
ACH208, whereas none of the clusters of nonidentical se-
quences were supported by bootstrap values over 70 in
ACH039.
Phylogenetic trees based on the gp120 V3 region yielded
a bootstrap supported division between the R5 and X4 virus
population in both patients (van Rij et al., 2000). However,
no separate clustering between R5 and X4 HIV-1 variants
was observed in the gag p17-based tree (Fig. 2). This im-
plies that R5 and X4 variants cannot be distinguished based
on gag p17 sequences.
To further substantiate this, we calculated the divergence
of all virus sequences to the consensus sequence from the
first available time point, which was 5 and 6 months before
the emergence of X4 variants in ACH039 and ACH208,
respectively. As the first time point is taken relatively early
after seroconversion (11 and 8 months, respectively), this
consensus sequence is likely to reflect the founder sequence
of the virus population. Ongoing genetic evolution was
observed for both R5 and X4 virus variants in gp120 V3
(Fig. 3A) and gag p17 (Fig. 3B) in both patients. A signif-
icant correlation was observed between the distance to the
founder sequence and time. This correlation remained sig-
nificant when the analyses were restricted to either the R5 or
the X4 virus populations (data not shown). Linear regres-
sion analyses yielded slopes that were significantly different
from zero (data not shown).
Next, we analyzed the diversity within the R5 virus
population, within the X4 virus population and the diver-
gence between the R5 and X4 virus populations over time.
Divergence between the R5 and X4 virus population in-
creased over time and always exceeded diversity within the
R5 or the X4 virus population in the gp120 V3 region (Fig.
4A). In contrast, the divergence from R5 to X4 virus pop-
ulation in the gag p17 region was similar to the diversity
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within the R5 or the X4 virus population (Fig. 4B). The
divergence from the R5 to the X4 virus population in the
gp120 V3 region was significantly higher than the diversity
within the R5 and X4 virus population at all time points (P
values ranging from 0.001 to 0.01, Mann–Whitney U
test), whereas no significant differences were observed in
the gag p17 region. In conclusion, we observed an ongoing
evolution of the gag p17 region of both R5 and X4 virus
populations, but these virus populations did not diverge
over time. Discordant positioning in phylogenetic trees
based on different genomic regions may reflect the occur-
rence of recombination (Robertson et al., 1995a,b; Posada et
al., 2002). Therefore, these results suggested that genetic
recombination between the R5 and X4 virus populations
Fig. 1. Deduced amino acid sequences of gag p17 sequences of biological virus clones from patient ACH039 (A) and ACH208 (B). Data on chemokine
receptor usage (ChemRec) were available from a previous study (van Rij et al., 2000). Time in months to the estimated emergence of X4 variants in vivo
at which samples were taken for isolation of virus clones are indicated. Dots indicate identity to the top sequence. Dashes indicate gaps that were introduced
for correct alignment. Annotation in the top line are derived from the HIV sequence compendium 2000 (Kuiken et al., 2000).
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may occur within an infected individual. To test this hy-
pothesis, we performed a statistical evaluation to detect
recombination using the Shimodaira–Hasegawa (SH) topol-
ogy test using the approach described in detail under Ma-
terials and methods. The results of the topology tests
strongly supported the hypothesis that recombination had
occured between the two genomic regions examined from
each patient and that the clear dissimilarities in the phylo-
genetic trees reconstructed from each region were greater
than expected under the null hypothesis of clonality. Table
2 shows that, for both regions from both patients, the to-
pology suggested by the opposing data is significantly
worse. The difference inLn likelihood values between the
topology from the opposing data and the ML topology is
much greater than expected under the null hypothesis that
both regions share the same underlying tree. In other words,
there is strong evidence of recombination among the the
virus populations within each host. Given that the mono-
phyly of the R5 and X4 virus populations observed in the
V3 region trees is not observed in the p17 trees, it follows
that recombination between R5 and X4 variants occurs in
vivo.
Although there were large and significant differences in
-Ln likelihood scores for the best tree for each region versus
the tree indicated by the other region, in three of the four
comparisons shown in Table 2 this difference was still
smaller than observed in all 100 random trees (data not
shown). This indicates that there is some similarity between
the p17 and gp120 V3 based trees, despite the recombina-
tion that was observed between these regions. However, for
Table 1
Average rates of synonymous (Ps) and nonsynonymous (Pn) mutations per potential site in gag p17 and env gp120 sequences
of virus clones from patients ACH039 and ACH208*
p17 gp120
ps pn ps/pn p (ps  pn) ps pn ps/pn p (ps  pn)
ACH039
Average 0.0347 0.0099 3.505 0.0248 0.0185 0.0406 0.456 0.0221
SE 0.0082 0.0029 1.319 0.0087 0.0064 0.0068 0.175 0.0093
ACH208
Average 0.0298 0.0159 1.874 0.0139 0.0262 0.0573 0.457 0.0311
SE 0.0076 0.0038 0.655 0.0085 0.0085 0.0121 0.177 0.0148
* Standard errors of the ratio ps/pn and the difference between ps and pn (p) were calculated as described by Rodrigo and Mullins (1996).
Fig. 2. Neighbor-joining phylogenetic tree of gag p17 sequences of ACH039 and ACH208. Symbols indicate time points in months relative to the first
detection of X4 variants at which viral clones were derived. Filled symbols indicate X4 virus clones; open symbols indicate R5 clones. Numbers in the
phylogenetic tree indicate clusters of nonidentical sequences that were supported bootstrap values over 70 based on 100 replicates. For clarity all
CXCR4-utilizing variants, including those that were able to use CCR3 and/or CCR5 in addition, are depicted as X4.
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the V3 region of patient ACH039, the p17 topology was not
significantly better than the random topologies. The ob-
served difference of 427.14 was greater than that observed
in 22 of the 100 random topologies. This result could imply
extensive recombination between the gag and env region,
but might also be due to weak phylogenetic signal in one of
the regions.
There was also evidence for recombination within both
the V3 and the p17 regions from each patient, although this
was not as strong as the evidence for recombination be-
tween the regions. Using the same procedure as outlined
above, we compared topologies generated from the up-
stream versus downstream halves of each genomic region
from each patient, for a total of eight more SH tests. Six of
eight of these comparisons were significant at the 0.05 level
(data not shown). For the gp120 V3 sequences of patient
ACH039, while the first 174 nucleotides supported a tree in
which the R5 and X4 variants formed clear monophyletic
groups, in the tree for the remaining 174 nucleotides the R5
and X4 virus populations intermingled in a manner similar
to the p17 tree shown in Fig. 2. This suggests that recom-
bination may play a role in the evolution of coreceptor
usage by shuffling, between viral lineages, the suite of
amino acid alterations in the V3 region that are responsible
for changes in coreceptor use.
Discussion
In this study we analyzed the genetic evolution of the
envelope gp120 V3 region and of the gag p17 region of
biological HIV-1 clones obtained from two patients who
developed X4 HIV-1 variants in the course of infection. We
observed an ongoing evolution of both the gag p17 region
and the gp120 V3 region over time, in both the R5 and the
X4 virus population. The R5 and X4 virus populations
continuously diverged from each other in the gp120 V3
region, but not in the gag p17 region. A separate clustering
Fig. 3. Divergence of R5 and X4 variants from the consensus sequence of the first time point over time. Uncorrected pairwise distances between the (A) gp120
V3 and (B) gag p17 sequences of the consensus sequence of the first time point and all sequences at each time point are analyzed. Open symbols indicate
R5 clones; filled symbols indicate X4 clones. Overlapping symbols have been shifted in a horizontal direction to visualize all symbols.
Fig. 4. Diversity within the R5 and X4 virus population and divergence between R5 and X4 virus populations over time. Averages of the uncorrected pairwise
distances between (A) gp120 V3 and (B) gag p17 sequences of patient ACH039 and ACH208 are analyzed. Error bars represent standard deviations. Open
circles indicate the diversity within the R5 virus population; filled circles indicate diversity within the X4 virus population. Open triangles indicate divergence
between the R5 and X4 virus population.
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between R5 and X4 variants was observed in env-based
phylogenetic trees (van Rij et al., 2000), whereas this was
not the case in gag p17 based trees. This can especially be
appreciated in the case of the R5 variant  1g4b, which
clusters with R5 variants in env-based trees, but intermin-
gles with X4 variants of the same time point (35 months
after X4 conversion) in Fig. 2. Indeed, the Shimodaira–
Hasegawa tests indicated that the two regions evolved along
significantly different topologies, a hallmark of recombina-
tion. These results imply that genetic recombination be-
tween the R5 and X4 virus populations occurs within an
individual.
It has been shown that HIV-1 is highly prone to recom-
bination. In vitro, recombination leads to the rapid spread of
antiretroviral drug resistance-associated mutations in coin-
fections with resistant and sensitive viruses (Kellam and
Larder, 1995; Moutouh et al., 1996). A large number of
inter-subtype recombinant viruses have been identified in
geographic regions where multiple subtypes are prevalent
(Robertson et al., 1995a,b; Neilson et al., 1999). Although
more difficult to detect, recombination has also been ob-
served in individuals who are infected with multiple strains
of HIV-1 of the same subtype (Diaz et al., 1995; Zhu et al.,
1995).
Recombination between different virus strains requires
superinfection of a single cell. From a dually infected cell,
heterodimeric virions will be generated. After infection of a
new cell, mosaic proviruses containing genetic information
of both RNA strands may be generated during reverse
transcription. Per replication cycle, HIV-1 undergoes ap-
proximately two to three recombination events between the
two genomic RNA molecules in the virion (Jetzt et al.,
2000). Recently it has been shown that an unanticipated
high percentage of infected CD4 cells in the spleen (75–
80%) contain at least two proviruses per cell. Per infected
cell, on average 3.2 proviruses were detected (with a range
of 1 to 8) (Jung et al., 2002). Although difficult to match
with a low number of cells carrying integrated provirus and
productively infected cells (Chun et al., 1995, 1997; Blaak
et al., 1997), the findings by Jung et al. indicate that super-
infection occurs at higher rates than previously anticipated.
Our observation that recombination between R5 and X4
HIV-1 variants does occur in vivo is seemingly in conflict
with our previous hypothesis that these variants may infect
mutually exclusive target cells (CCR5 CXCR4 memory
cells and CCR5 CXCR4 memory and naive cells, respec-
tively), thus allowing coexistence without out-competition
of the least-fit variants (van Rij et al., 2000). The presence
of a proportion of CCR5 CXCR4 double-positive cells
that can be infected by both R5 and X4 HIV-1 variants may
explain superinfection and recombination between R5 and
X4 variants. An alternative explanation may be based on the
differential tropism of R5 and X4 variants tropism for
CCR5 and CXCR4 cells. Whereas CCR5 is mainly ex-
pressed on activated memory CD4 T cells, CXCR4 is
expressed mainly on naive and resting memory CD4 T
cells (Bleul et al., 1997; Blaak et al., 2000). It is thought that
productive infection does not occur in resting cells due to
blocks in essential steps in the viral life cycle (Bukrinsky et
al., 1991; Zack et al., 1990, 1992). However it was recently
shown that reverse transcription can proceed to completion
in resting cells resulting in full-length cDNA that is pro-
cessed by integrase, albeit at a lower rate than in activated
cells (Pierson et al., 2002). Likewise, in resting CXCR4
cells infected with X4 variants reverse transcription and
integration may occur, resulting in a long-lived, nonlytic or
latently infected cell. Upregulation of CCR5, e.g., after
activation of the cell, allows subsequent infection by R5
variants. This will result in a cell carrying both a R5 and a
X4 provirus, thus providing the requirement for recombina-
tion between R5 and X4 HIV-1 variants.
In conclusion, recombination seems to be a general phe-
nomenon of the life cycle of HIV-1. Our data confirm and
extend the previous studies by showing that recombination
between R5 and X4 variants can occur as well.
Materials and methods
Patients and viruses
We analyzed biological virus clones from two patients
(ACH039 and ACH208) who developed X4 variants during
follow-up in the Amsterdam cohort on HIV-1 infection and
AIDS. In this cohort, the presence of syncytium-inducing,
CXCR4-utilizing variants is prospectively determined by
cocultivation of patient peripheral blood mononuclear cells
(PBMC) with the MT2 T cell line. The moment of first
emergence of X4 variants in vivo was estimated as the
midpoint between the last SI-negative visit and the first
SI-positive visit, which was at 16 and 14 months after
seroconversion in patient ACH039 and ACH208, respec-
tively. The AIDS diagnosis was made at 22 (ACH039) and
42 (ACH208) months after the evolution of X4 HIV-vari-
ants. Biological virus clones were obtained by cocultivation
Table 2
Shimodaira–Hasegawa (SH) test results for p17 and V3 regions
from patients ACH039 and ACH0208*
Patient Region Tree -In L Diff-In L P
p17 MLp17 932.63844 (best)
MLv3 1066.54367 133.90523 0.001
ACH039
V3 MLp17 1442.72211 427.14209 0.001
MLv3 1015.58002 (best)
p17 MLp17 1093.60106 (best)
MLv3 1303.80397 210.20291 0.001
ACH0208
V3 MLp17 840.45464 290.99429 0.001
MLv3 549.46034 (best)
* The two topologies depicted for each test are the relevant ones for the
test of recombination; comparisons to random topologies are omitted from
this table.
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of patient PBMC with phytohemagglutinin (PHA)-stimu-
lated PBMC from healthy blood donors under limiting di-
lution conditions. Virus clones derived from patient PBMC
from several time points before and after the first detection
of X4 variants and data on viral coreceptor preferences were
available from a previous study (van Rij et al., 2000).
Sequence analyses
gag p17 and env sequences were obtained by nested PCR
performed on DNA from healthy donor PHA-PBMC that
were infected with single virus clones. Gag and env se-
quences obtained this way are therefore derived from the
same viral genomes and can be linked directly to phenotypic
data on these virus clones. Primary PCR for gag sequences
was performed with primers m667 (5-GGCTAACTAGG-
GAACCCACTG-3, position 496 to 516 in HxB2) (Zack et
al., 1990) and gag-c2 (5-TCTGATAATGCTGAAAA-
CATGGG-3, position 1297 to 1319) (Hughes et al., 1997).
Nested PCR was performed with primers gag-c1 (5- GC-
GAGAGCGTCAGTATTAAGCGG-3, position 796 to
818) and p17-2 (5- CTTCTACTACTTTTACCCATGC-3,
position 1249 to 1270) (Hughes et al., 1997). PCR products
were purified and sequenced with the BigDye terminator
sequencing kit (Perkin–Elmer, Foster City, CA) using the
same primers as were used for nested PCR. Sequences were
analyzed on an ABI Prism 377 DNA sequencer. Newly
generated sequences are deposited in GenBank under Ac-
cession Nos. AY139425 to AY139457 (ACH039) and
AY139458 to AY139501 (ACH208). Envelope sequences
from the same virus clones were described in a previous
study (van Rij et al., 2000).
Phylogenetic analyses
Sequences were aligned using ClustalW (version 1.7)
(Thompson et al., 1994), checked manually, and displayed
using Genedoc (http://www.psc.edu/biomed/genedoc/). For
all phylogenetic analyses, gaps that were introduced for
correct alignment were removed from all sequences. After
deleting the gaps 412 (ACH039) and 429 (ACH208), nu-
cleotides were available for phylogenetic analyses. HxB2
(Accession No. K03455) was used as an outgroup in phy-
logenetic trees. An unrooted phylogenetic tree was pro-
duced using the neighbor-joining approach as implemented
in the Phylip package (version 3.5c) (Felsenstein, 1989).
Distance matrices for construction of phylogenetic trees
were produced using Phylip’s DNADIST using the maxi-
mum likelihood model for nucleotide substitutions, which
corrects for differences in nucleotide frequencies and tran-
sition to transversion (Ti/Tv) ratios. Puzzle (version 4.0.2)
(Strimmer & Von Haeseler, 1996) was used to estimate
Ti/Tv ratios, which were used as input in DNADIST (Ti/Tv
ratio of 2.50 in the phylogenetic tree of Fig. 2). Bootstrap
analyses were performed using SEQBOOT, DNADIST,
NEIGHBOR, and CONSENSE (Phylip package). Phylip’s
DRAWTREE was used to prepare the plots. Average rates
of synonymous (ps) and nonsynonymous substitutions (pn)
per potential site were estimated using the method of Nei
and Gojobori (1986) as implemented in MEGA (version
1.02) (Kumar et al., 1994). Standard errors for the differ-
ence between ps and pn (p) and for the ratio ps/pn were
calculated as described by Rodrigo and Mullins, based on
the MEGA estimate of the standard error of the overall
average of ps and pn (Rodrigo and Mullins, 1996). Distance
matrices of the uncorrected proportion of differences were
produced in MEGA. All statistical analyses were performed
using SPSS software (version 10.0, SPSS Inc., Chicago, IL).
P values of 0.05 and lower were considered statistically
significant.
Statistical evaluation of recombination
If there has been no recombination in the history of a set
of sampled sequences, then there has been complete linkage
between the different regions of its genome. In other words,
there is one true tree (topology) that accurately describes
their evolution. The true tree cannot be known for certain,
but any difference between estimated topologies derived by
analyzing different partitions of the data (e.g., the p17 or the
V3 region) should reflect only sampling error. On the other
hand, evidence that the topologies are significantly different
can be taken as evidence that recombination has occured
and that different regions have independent evolutionary
histories.
To test the hypothesis of recombination among the bio-
logical clones sampled from each patient, we used the SH
test (Shimodaira and Hasegawa, 1999), as implemented in
PAUP* (Swofford, 2002), to ask whether the different
genomic regions appeared to have evolved along different
topologies. The SH test is an appropriate nonparametric test
for comparing two or more topologies in the case where one
of these is the maximum likelihood tree (Shimodaira and
Hasegawa, 1999; Goldman et al., 2000). The procedure was
as follows.
1. We used the p17 data to generate the estimated max-
imum likelihood (ML) topology for that region and
used the V3 data to find the ML topology for that
region. In each case, the parameters of a general time
reversible (GTR) nucleotide substitution model with
gamma distributed among-site rate variation were es-
timated on a neighbor-joining tree and then used in a
heuristic ML tree search with subtree-pruning-regraft-
ing (SPR) branch swapping (Swofford, 2002).
2. Using the p17 data, we ran an SH test (1000 bootstrap
replicates, RELL approximation) that included the
ML topology estimated for that region, as well as the
ML topology derived from the V3 region. Although
the SH test has been shown to be relatively conser-
vative compared to other likelihood-based tests of
topologies (Goldman et al., 2000), comparisons of
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small numbers of topologies may be biased toward
higher levels of significance than when more topolo-
gies are included (M. Worobey, unpublished results).
Hence, to make the test for recombination more con-
servative, we included 100 random topologies and the
ML topology for the combined data, for a total of 103
topologies.
3. Using the V3 data, we ran an SH test comparing the
ML topology for that region, the ML topology for the
p17 region, the 100 random topologies, and the ML
topology from the combined data. Recombination
was inferred if in each case (i.e., for the p17 and for
the V3 data) the ML topology from the opposing
genomic region was found to be significantly different
from the ML topology for that region.
The evaluation of random topologies served another pur-
pose as well. In principle, if there has been enough recom-
bination in the history of the data in question to break down
almost all the linkage disequilibrium between sites, then
each site is expected to have evolved down an independent
path. In that case a topology estimated from one genomic
region may not be significantly better than a random tree
when applied to the data from another region. Thus, for each
region we asked whether the difference in -Ln likelihood
between the ML topology and the topology from the op-
posing region was better than difference between the -Ln
likelihood between the ML topology and 95% of the ran-
dom trees.
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